Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • EEM vs GSK✓SelectedUSD · GSKEEM vs GSK performance historyLatest closeAs of-0.36%11/13
Stock and ETF performance explorer

EEM vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+746.2%
GSK return
+293.5%
Excess return
+452.7%
Maximum drawdown
-66.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.4%+0.5%-0.9%-0.6%
7D+2.7%+1.1%+1.5%+2.1%
30D-5.4%+6.3%-11.7%-8.7%
3M-8.6%+1.8%-10.5%-10.2%
6M-8.9%+1.7%-10.5%-11.2%
YTD+11.9%+6.5%+5.4%+5.3%
1Y+13.1%+9.5%+3.6%+4.7%
3Y+70.7%+65.3%+5.3%+18.8%
5Y+31.8%+43.7%-12.0%-3.6%
10Y+119.5%+104.1%+15.4%+21.2%
All+746.2%+293.5%+452.7%+233.6%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling